STANLEY D. GRATZ
******@*******.***
**** **** **** **. (H): 215-***-****
Huntingdon Valley, PA 19006 (C): 267-***-****
QUALITY ASSURANCE / CHEMIST
Extensive experience managing quality assurance in pharmaceutical manufacturing environments for industry leaders including McNeil. Demonstrated success in delivering improvements in testing procedures, creating SOPs and driving quality control processes to ensure compliance with FDA regulations. Experience in new facility set-up and quality management. Broad command of all types of production and QC laboratory equipment. Thoroughly trained in cGMP and FDA requirements. Broad product knowledge covering tablets, capsules, liquids sprays and gels. Exceptional analytical skills applied to driving optimal quality in manufacturing and production.
• Quality Control • Product Formulations • cGMP
• Regulatory Compliance • Laboratory SOPs • Validation Studies
• Manufacturing SOPs • Stability System 2008 • Testing
• New Facility Set-Up • IQ/OQ/PQ • Quality Training
B.S., Chemistry (Minor – Pharmacy) – Philadelphia College of Pharmacy and Science.
A.S., QA/RA – Temple University College of Quality Assurance and Regulatory Affairs.
Career History
Quality Assurance – KVK-TECH, Inc (Newtown, PA) 2010-2010. Wrote SOP’s and Validation Protocols. I was involved with the CMC section for ANDA and writing the QBR’s.
Quality Assurance / Chemist – Cetylite Industries, Inc. 1993 – 2009. Supervised QC and QA departments in this pharmaceutical and medical device manufacturing company. Purchased new QC lab equipment and trained personnel in their use including: HPLCs, FTIR, UV, GCMS, Karl-Fisher and all other lab equipment related to testing and release of both raw and finished products. Developed and performed all IQ/OQ/PQ operations on both the laboratory equipment and the manufacturing equipment. Developed and performed all types of validation procedures for finished dosage forms and the D.I. Water system including all cleaning validations for the manufacturing equipment.
• Implemented use of new formulation and packaging rooms to remediate fifteen 483
observations from the FDA. Developed and wrote all new SOPs along with designing new
rooms, purchasing new equipment and creating proper flow to meet cGMP requirements. FDA
had issued no observations in both QC and manufacturing subsequent to the improvements.
• Purchased and operated new comprehensive stability study system using Stability System 2008
to replace my own stability program developed in MS Access.
• Instituted a new SOP system and wrote all SOPs for all departments in the company. Drew
upon extensive previous experience in writing and implementing SOPs and procedures for both
QA/QC and production departments.
Stanley D. Gratz Page 2
Quality Assurance / Chemist – JWS Delavau 1992 – 1993. Worked with QC and QA departments in testing pharmaceutical tablets and revamping their SOPs and laboratories. Performed all types of testing on in-process and finished tablet production including dissolution, friability, tap density, hardness and assay. Responsible for all aspects of daily quality assurance operations including writing SOPs, inspections, complaints, outside contractors, customers, FDA inspections and all other related operations.
• Formalized procedures in formulation and production to align with FDA quality standards.
Corrected deficiencies in cGMP requirements and poor production procedures. Brought
manufacturing and formulation operations into compliance with FDA regulations. Re-wrote
SOPs and assisted in training personnel in cGMPs and other FDA requirements.
• Purchased and validated a new D.I. Water system for finished dosage forms.
Quality Control Chemist – McNeil CPC 1991 – 1992. Responsible for testing of both raw materials and finished products. Performed all types of testing on many products including Tylenol PM, including HPLC analysis and GC Headspace analysis. Tested bulk granulations including tap density and sieve analysis. Tested finished tablets for friability and dissolution.
• Developed new analysis method using less solvents for HPLC analysis of Tylenol PM,
reducing solvent volume by 50%. Modified and ran a validation on HPLC method with
comparative validation against old method.
• Improved assay method for Tylenol PM which decreased time and solvent requirements for the
assay.
Quality Control Director / Chemist – Lannett Co., Inc. 1975 – 1991. Served as a chemist and Quality Control Director for this generic pharmaceutical manufacturer of tablets, capsules, liquids and ointments.
• Worked in both production and formulations of all types of tablets and capsules. Developed
and improved ease of production along with dissolution, quality and stability. Extensive
experience with formulation ingredients required for tablet and capsule production.
• Purchased Lannett’s first HPLC in 1976, attaining expert proficiency in HPLC. Adept at
managing HPLC method development, validation, stability method development and improving
older methods for speed and separation and maintenance. Developed several methods currently
in use by USP.
• Performed all types of testing on in-process and finished tablet production including
dissolution, friability, tap density, hardness and assay.
• Purchased all new QC lab equipment and trained personnel in HPLCs, FTIR, UV, GCMS,
Karl-Fisher and all other lab equipment related to the testing and release of both raw and
finished products.
• Developed and performed al IQ/OQ/PQ operations on both the laboratory equipment and
manufacturing equipment.
• As Director of Quality Assurance, responsible for all aspects of daily operations including
writing SOPs, inspections, complaints, outside contractors, customers and FDA inspections.